Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in J Invest Dermatol Retrieve available abstracts of 91 articles: HTML format

Single Articles

June 2026
1. SACKNOVITZ Y, Ma R, Zhou MH, Kent J, et al
   Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis.
   J Invest Dermatol. 2026 Jun 10:S0022-202X(26)02599.
   PubMed    
   
   
   
2. ZHAO Q, Leguina-Ruzzi A, Tominaga M, Kamata Y, et al
   Psychological stress delays inflammatory resolution and promotes sustained sensory sensitization during recovery from atopic dermatitis.
   J Invest Dermatol. 2026 Jun 9:S0022-202X(26)02596.
   PubMed    
   
   
   
3. PETERS RHW, Smits JPH, van den Bogaard EH, Kelemen E, et al
   Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
   J Invest Dermatol. 2026 Jun 5:S0022-202X(26)01200.
   PubMed     Abstract available
   
   
   
4. YANG K, Mircescu A, Okusanya D, Mohsen S, et al
   Understanding the Atopic Dermatitis-Psoriasis Phenotypic Switch Through a Pharmacovigilance-Based Approach.
   J Invest Dermatol. 2026 Jun 1:S0022-202X(26)01267.
   PubMed    
   
   
   May 2026
5. STRATIGOS A, Steinhoff M, Luger T, Tan J, et al
   Impact of atopic dermatitis on education and career choices: the Scars of Life international study.
   J Invest Dermatol. 2026 May 28:S0022-202X(26)01041.
   PubMed    
   
   
   
6. YEUNG K, Weber JF, Stegenborg-Grathwohl SM, Hu T, et al
   Anakinra alters epidermal tissue-resident memory T cell profiles but fails to reduce clinical responses upon nickel re-challenge in individuals with nickel allergy.
   J Invest Dermatol. 2026 May 8:S0022-202X(26)01190.
   PubMed    
   
   
   
7. CHEN R, Miltner LA, Loman L, Schuttelaar MLA, et al
   ADULTS WITH ATOPIC DERMATITIS AND ATOPIC MULTIMORBIDITY EXPERIENCE IMPAIRED SLEEP QUALITY.
   J Invest Dermatol. 2026 May 7:S0022-202X(26)01188.
   PubMed    
   
   
   
8. WOLLAM J, Solomon M, Villescaz C, Srinivasan S, et al
   MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis.
   J Invest Dermatol. 2026 May 4:S0022-202X(26)01182.
   PubMed     Abstract available
   
   
   April 2026
9. WITTE F, Wiegmann H, Teitge E, Westmeier J, et al
   Evaluation of Itch Intensity Scales in Atopic Dermatitis: Differential Measurement Properties and Associations with Relevant Cytokines.
   J Invest Dermatol. 2026 Apr 20:S0022-202X(26)01046.
   PubMed     Abstract available
   
   
   March 2026
10. TRUJILLO A, Munguia N, Craig N, Wilkes R, et al
    Genome-wide Study Identifies a Locus Associated with Atopic Dermatitis Severity in a Canine Model.
    J Invest Dermatol. 2026 Mar 25:S0022-202X(26)01000.
    PubMed    
    
    
    
11. JIANG W, Xie X, Yang S, Xu R, et al
    Basophil Activity in Atopic Dermatitis: Distinct Immunomodulatory Roles of Dupilumab and Abrocitinib.
    J Invest Dermatol. 2026 Mar 9:S0022-202X(26)00746.
    PubMed     Abstract available
    
    
    
12. OTROFANOWEI E, Ahogo KC, Atadokpede F, Bahloul E, et al
    Accessibility And Affordability Of Emollients In The Management Of Atopic Dermatitis (AD) In Africa.
    J Invest Dermatol. 2026 Mar 2:S0022-202X(26)00137.
    PubMed     Abstract available
    
    
    February 2026
13. XIAO F, Wu R, Wu N, Xie Y, et al
    Fat mass and obesity-associated (FTO)/SOCS6-m(6)A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00068.
    PubMed     Abstract available
    
    
    January 2026
14. DUBRAC S, Combarros D, Olah A, Cadiergues MC, et al
    Recommendations on in vitro models for canine atopic dermatitis.
    J Invest Dermatol. 2026 Jan 20:S0022-202X(25)03668.
    PubMed    
    
    
    December 2025
15. KIM KC, Lee JH
    Harnessing cannabidiol: an approach to attenuating Th2 inflammation via JAK/STAT signaling and modulating CB2 receptor in atopic dermatitis.
    J Invest Dermatol. 2025 Dec 15:S0022-202X(25)03640.
    PubMed    
    
    
    November 2025
16. BISSONNETTE R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al
    Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers.
    J Invest Dermatol. 2025 Nov 18:S0022-202X(25)03550.
    PubMed     Abstract available
    
    
    
17. KAWAKAMI E
    Dynamic Network Biomarker Analysis Reveals Predisease State in Atopic Dermatitis.
    J Invest Dermatol. 2025 Nov 11:S0022-202X(25)03458.
    PubMed    
    
    
    
18. PARK JJ, Richards D, Tseng PH, Ebata T, et al
    Methods to Validate Digital Health Technologies for Dermatology.
    J Invest Dermatol. 2025;145:2668-2675.
    PubMed     Abstract available
    
    
    October 2025
19. MISERY L, Talagas M, Le Gall-Ianotto C
    Dupilumab's Effects on Itch Sensitization in Atopic Dermatitis.
    J Invest Dermatol. 2025 Oct 21:S0022-202X(25)02477.
    PubMed    
    
    
    September 2025
20. SENSUI T, Iwasaki K, Aihara K
    Identification of Pre-Disease State in NC/Nga Mice with Atopic Dermatitis-Like Symptoms Using Dynamical Network Biomarkers.
    J Invest Dermatol. 2025 Sep 22:S0022-202X(25)02436.
    PubMed     Abstract available
    
    
    
21. SCHNEIDERMAN M
    Association of Adult Atopic Dermatitis and Repetitive Strain Injury: A U.S. Population-Based Study.
    J Invest Dermatol. 2025 Sep 19:S0022-202X(25)02435.
    PubMed    
    
    
    
22. BASH GN, Baghoomian W, Seshadri R, Latour E, et al
    Aberrant Epidermal Innervation in Adults with Atopic Dermatitis is Restored Following Dupilumab Treatment.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02424.
    PubMed    
    
    
    
23. GALLO RL
    Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02325.
    PubMed    
    
    
    
24. BURSHTEIN J, Bunick CG, Vleugels RA, Armstrong AW, et al
    Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy.
    J Invest Dermatol. 2025 Sep 6:S0022-202X(25)02338.
    PubMed    
    
    
    
25. KROGH NS, Prieto-Merino D, Coker B, Birkner T, et al
    Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
    J Invest Dermatol. 2025 Sep 3:S0022-202X(25)02407.
    PubMed     Abstract available
    
    
    
26. WANG Q, Qiu Q, Sun H, Liu Y, et al
    Distinct Comorbidity Clusters and Their Genetic Associations with Atopic Dermatitis in Middle-Aged and Elderly Adults.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02404.
    PubMed    
    
    
    August 2025
27. WIEGMANN H, Witte F, Renkhold L, Westmeier J, et al
    Cutaneous neuroanatomical and cellular response to dupilumab treatment in atopic dermatitis.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02353.
    PubMed     Abstract available
    
    
    
28. BECKER SL, Bash GN, Begolka WS, Wallace-Hood T, et al
    Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys.
    J Invest Dermatol. 2025 Aug 13:S0022-202X(25)02337.
    PubMed     Abstract available
    
    
    
29. BUNICK CG
    Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action.
    J Invest Dermatol. 2025 Aug 5:S0022-202X(25)02203.
    PubMed     Abstract available
    
    
    
30. SHOBNAM N, Ratley G, Saksena S, Yadav M, et al
    Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
    J Invest Dermatol. 2025;145:1953-1968.
    PubMed     Abstract available
    
    
    July 2025
31. THOMOVA T, Jedlickova H, Bohm J, Holochova P, et al
    EFFECT OF SYSTEMIC THERAPIES ON SKIN BACTERIOME IN PATIENTS WITH ATOPIC DERMATITIS: A PILOT PROSPECTIVE STUDY.
    J Invest Dermatol. 2025 Jul 28:S0022-202X(25)02307.
    PubMed     Abstract available
    
    
    
32. BAZZINI C, Bertschi NL, Steck O, Luther F, et al
    Human T Helper 9 Cells Rely on Peroxisome Proliferator-Activated Receptor-gamma-Mediated Cystine Uptake to Prevent Lipid Peroxidation and Bioenergetic Failure.
    J Invest Dermatol. 2025;145:1693-1705.
    PubMed     Abstract available
    
    
    June 2025
33. BUNICK CG, Armstrong AW, Grada A, Soliman AM, et al
    The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States.
    J Invest Dermatol. 2025 Jun 26:S0022-202X(25)02236.
    PubMed     Abstract available
    
    
    
34. GELLER S
    Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)00542.
    PubMed    
    
    
    
35. WANG J, Ho M, Bunick CG
    Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.
    J Invest Dermatol. 2025;145:1471-1488.
    PubMed     Abstract available
    
    
    May 2025
36. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    PubMed     Abstract available
    
    
    
37. FUNCH AB, Weber JF, Mraz V, Kongsbak-Wismann M, et al
    CD8(+) Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00529.
    PubMed     Abstract available
    
    
    
38. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    PubMed     Abstract available
    
    
    
39. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    PubMed    
    
    
    
40. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    PubMed     Abstract available
    
    
    April 2025
41. STAMATAS GN, Insel R, Sorensen N, Palleja A, et al
    Shifts in Infant Skin Microbiome at 2 Months following Short-term Emollient Use from Birth are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00380.
    PubMed    
    
    
    March 2025
42. ZHANG H, Tang S, Chen X, Wang M, et al
    Association Between Emotional Distress and Atopic Dermatitis: A Cross-Sectional Study.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00365.
    PubMed    
    
    
    
43. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    PubMed     Abstract available
    
    
    
44. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    PubMed     Abstract available
    
    
    February 2025
45. INGEN-HOUSZ-ORO S, Matei I, Gaillet A, Gueudry J, et al
    Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00078.
    PubMed     Abstract available
    
    
    
46. KAMP E, Ascott A, George SMC
    Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.
    J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00099.
    PubMed     Abstract available
    
    
    January 2025
47. HU J, Zhao Q, Che D, Peng B, et al
    Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle via TRPA1 Activation on Mast Cells in Atopic Dermatitis.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00076.
    PubMed     Abstract available
    
    
    
48. ABUABARA K, Kidd SA, Ye M, Tully J, et al
    The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
    PubMed     Abstract available
    
    
    
49. GOHARA Y, Kinoshita R, Tomonobu N, Jiang F, et al
    An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00029.
    PubMed     Abstract available
    
    
    
50. BRIOT J, Pons C, Foucher A, Goudouneche D, et al
    Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification.
    J Invest Dermatol. 2025;145:98-108.
    PubMed     Abstract available
    
    
    December 2024
51. AZEEM M, Helal M, Klein-Hessling S, Serfling E, et al
    NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03036.
    PubMed     Abstract available
    
    
    
52. TANDON R, Harder I, Stolzl D, Hubenthal M, et al
    Tralokinumab Treatment of Atopic Dermatits Induces A Progressive Transcriptomic Response.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03035.
    PubMed     Abstract available
    
    
    
53. ISKANDAR RJ, Drucker AM
    A Framework to Efficiently Monitor the Comparative Safety of Systemic Immunomodulatory Medications for Atopic Dermatitis.
    J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02961.
    PubMed    
    
    
    
54. BRAHIMI N, Croitoru D, Saidoune F, Zabihi H, et al
    From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
    J Invest Dermatol. 2024 Dec 10:S0022-202X(24)01883.
    PubMed     Abstract available
    
    
    November 2024
55. YEW YW, Loh M, Brown SJ
    Understanding Atopic Dermatitis in Asian and European Population Cohorts Using Complementary Omics Techniques.
    J Invest Dermatol. 2024 Nov 5:S0022-202X(24)02171.
    PubMed     Abstract available
    
    
    
56. MASISON J, Lehmann HP, Wan J
    Utilization of Computable Phenotypes in Electronic Health Record Research: A Review and Case Study in Atopic Dermatitis.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02103.
    PubMed     Abstract available
    
    
    October 2024
57. DAI X, Mizukami Y, Watanabe K, Tsuda T, et al
    Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro.
    J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02175.
    PubMed     Abstract available
    
    
    
58. SCHNEEWEISS MC, Glynn RJ, Wyss R, Anand P, et al
    A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice.
    J Invest Dermatol. 2024 Oct 1:S0022-202X(24)02169.
    PubMed     Abstract available
    
    
    September 2024
59. FRISOLI ML, Ko WC, Martinez N, Afshari K, et al
    Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis.
    J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02152.
    PubMed     Abstract available
    
    
    
60. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
    Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
    PubMed     Abstract available
    
    
    August 2024
61. LI Y, Chen W, Zhu X, Mei H, et al
    Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.
    J Invest Dermatol. 2024;144:1829-1842.
    PubMed     Abstract available
    
    
    June 2024
62. HUANG KR, Mai-Yi Fan S, Tai KY, Lin JD, et al
    Essential role of macrophages in contact hypersensitivity-induced hair regeneration.
    J Invest Dermatol. 2024 Jun 25:S0022-202X(24)01739.
    PubMed    
    
    
    
63. SHIOHARA T, Mizukawa Y
    The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.
    J Invest Dermatol. 2024 Jun 22:S0022-202X(24)00381.
    PubMed    
    
    
    
64. MA X, Zhao H, Song JK, Zhang Z, et al
    Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
    J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
    PubMed     Abstract available
    
    
    
65. SHEN S, Sobczyk MK, Paternoster L, Brown SJ, et al
    From GWASs toward Mechanistic Understanding with Case Studies in Dermatogenetics.
    J Invest Dermatol. 2024;144:1189-1199.
    PubMed     Abstract available
    
    
    May 2024
66. SONG Z, Gao M, Li T, Zhang Y, et al
    TRPV3-activated PARP1/AIFM1/MIF axis through oxidative stress contributes to atopic dermatitis.
    J Invest Dermatol. 2024 May 30:S0022-202X(24)00384.
    PubMed     Abstract available
    
    
    
67. BORZUTZKY A, Cabalin C
    From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
    J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
    PubMed    
    
    
    
68. SCHMUTH M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, et al
    Skin Barrier in Atopic Dermatitis.
    J Invest Dermatol. 2024;144:989-1000.
    PubMed     Abstract available
    
    
    
69. BROWN SJ, Gudjonsson JE
    Halting the Vicious Cycle of Atopic Dermatitis: Empowered by Scientific Understanding.
    J Invest Dermatol. 2024;144:917-918.
    PubMed    
    
    
    April 2024
70. PASANEN A, Sliz E, Huilaja L, Reimann E, et al
    Identifying atopic dermatitis risk loci in 1,094,060 individuals with sub analysis of disease severity and onset.
    J Invest Dermatol. 2024 Apr 23:S0022-202X(24)00285.
    PubMed     Abstract available
    
    
    
71. VAN DEN BRINK NJM, Pardow F, Meesters LD, van Vlijmen-Willems I, et al
    Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00293.
    PubMed     Abstract available
    
    
    
72. PALLER AS, Scharschmidt TC, Kezic S, Irvine AD, et al
    Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area.
    J Invest Dermatol. 2024 Apr 2:S0022-202X(24)00186.
    PubMed     Abstract available
    
    
    March 2024
73. ARADI P, Kovacs G, Kemecsei E, Molnar K, et al
    Lymphatics-dependent modulation of the sensitization and elicitation phases of contact hypersensitivity.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00261.
    PubMed     Abstract available
    
    
    
74. SAHEB KASHAF S, Kong HH
    Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00082.
    PubMed     Abstract available
    
    
    
75. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
    Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
    PubMed    
    
    
    
76. ISHIMARU H, Nakamoto K, Yamane M, Yamamoto T, et al
    Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00196.
    PubMed     Abstract available
    
    
    
77. 
    WITHDRAWN: Expression of Concern: Zhou et al, Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Derm doi:10.1016/j.jid.2023.02.023.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00173.
    PubMed     Abstract available
    
    
    
78. DROLL SH, Zhang BJ, Levine MC, Xue C, et al
    CASZ1 is Essential for Skin Epidermal Terminal Differentiation.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00172.
    PubMed     Abstract available
    
    
    
79. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
    Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
    J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
    PubMed    
    
    
    
80. DAS M, Mukherjee S, Geha RS
    Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
    PubMed    
    
    
    
81. BRAHIMI N, Piguet V
    Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
    J Invest Dermatol. 2024;144:441-443.
    PubMed    
    
    
    
82. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
    Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
    J Invest Dermatol. 2024;144:708-710.
    PubMed    
    
    
    
83. WANG X, Mao D, Jia J, Zhang J, et al
    Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    J Invest Dermatol. 2024;144:509-519.
    PubMed     Abstract available
    
    
    February 2024
84. GALLO RL, Horswill AR
    Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
    PubMed     Abstract available
    
    
    
85. MUKHOPADHYAY S, Brown SJ
    FLG Knockdown-Related Skin-Lung Crosstalk Biologically Underpins an Filaggrin-Related Childhood Asthma Subtype.
    J Invest Dermatol. 2024 Feb 16:S0022-202X(24)00027.
    PubMed    
    
    
    January 2024
86. YEO H, Ahn SS, Ou S, Yun SJ, et al
    The EGR1-ARTN axis in keratinocytes enhances the innervation of epidermal sensory neurons during skin inflammation induced by house dust mite extract from Dermatophagoides farinae.
    J Invest Dermatol. 2024 Jan 30:S0022-202X(24)00090.
    PubMed     Abstract available
    
    
    
87. BIER K, Senajova Z, Henrion F, Wang Y, et al
    Interleukin-26 potentiates type 2 skin inflammation in presence of interleukin-1beta.
    J Invest Dermatol. 2024 Jan 16:S0022-202X(24)00017.
    PubMed     Abstract available
    
    
    November 2023
88. ZHANG W, Akhtar N, Zhao J, Spandau DF, et al
    Fibronectin promotes wound healing in an atopic human skin xenografting model.
    J Invest Dermatol. 2023 Nov 30:S0022-202X(23)03118.
    PubMed    
    
    
    
89. YU J, Song P, Bai Y, Dang E, et al
    CD36-SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis.
    J Invest Dermatol. 2023;143:2153-2162.
    PubMed     Abstract available
    
    
    
90. LIN FJ, Huang YH, Tsao CH, Hsieh WC, et al
    Galectin-12 Regulates Immune Responses in the Skin through Sebaceous Glands.
    J Invest Dermatol. 2023;143:2120-2131.
    PubMed     Abstract available
    
    
    October 2023
91. FUKUNAGA K, Tsukagoshi E, Kurata M, Mizukawa Y, et al
    Differential effects of HLA-B*15:11 and HLA-A*31:01 on carbamazepine-induced cutaneous adverse reactions.
    J Invest Dermatol. 2023 Oct 21:S0022-202X(23)02972.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum